ALG VERSUS OKT3 PROPHYLAXIS IN RENAL-TRANSPLANT PATIENTS WITH HIGH IMMUNOLOGICAL RISK

被引：0

作者：

OSORIO, JM ^{[1
]}

BIECHY, M ^{[1
]}

OSUNA, A ^{[1
]}

MARTINEZ, E ^{[1
]}

SORIANO, C ^{[1
]}

ASENSIO, C ^{[1
]}

机构：

[1] HOSP VIRGEN NIEVES,SERV NEFROL,GRANADA,SPAIN

来源：

KIDNEY INTERNATIONAL | 1994年 / 46卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：584 / 584

页数：1

共 50 条

[21] EFFECT OF OKT3 ANTIBODY THERAPY ON CYTOMEGALOVIRUS REACTIVATION IN RENAL-TRANSPLANT RECIPIENTS [J].

CHOU, S ;

NORMAN, DJ .

TRANSPLANTATION PROCEEDINGS, 1985, 17 (06) :2755-2756

[22] OKT3 IN SEVERE EARLY REJECTION - PREDICTORS FOR REVERSAL IN RENAL-TRANSPLANT RECIPIENTS [J].

SUMRANI, N ;

DELANEY, V ;

RAJPOOT, D ;

TEJANI, A ;

BUTT, K ;

HONG, J .

TRANSPLANTATION PROCEEDINGS, 1990, 22 (04) :1750-1752

[23] MORBIDITY OF INTRAOPERATIVE OKT3 ADMINISTRATION IN PRIMARY CADAVERIC RENAL-TRANSPLANT RECIPIENTS [J].

KUPIN, W ;

VENKAT, KK ;

IKEMIYASHIRO, D ;

OCDOL, H ;

MOZES, M ;

ANAISE, D ;

JOHNSON, C .

TRANSPLANTATION PROCEEDINGS, 1993, 25 (01) :572-574

[24] INTERVAL ALG THERAPY IN HIGH-RISK CADAVERIC RENAL-TRANSPLANT PATIENTS [J].

JARRELL, B ;

BURKE, J ;

YANG, S ;

KARSCH, R ;

BESARAB, A .

KIDNEY INTERNATIONAL, 1983, 23 (01) :291-291

[25] CYCLOSPORINE MONOTHERAPY VERSUS OKT3 AND CYCLOSPORINE VERSUS PREDNISONE AND CYCLOSPORINE AS INDUCTION THERAPY IN OLDER RENAL-TRANSPLANT PATIENTS - A MULTICENTER RANDOMIZED STUDY [J].

FRANCO, A ;

OLIVARES, J ;

GRINO, JM ;

MORENO, F ;

OPPENHEIMER, J ;

VILARDELL, J ;

CAPDEVILA, L ;

PIERA, L ;

ALONSO, A ;

VALDES, F ;

RENGEL, M ;

VALDERRABANO, F ;

MARCEN, R ;

RIVERA, MT ;

ANDRES, A ;

MORALES, JM ;

CABELLO, M ;

MOLINA, MG ;

ARIAS, M ;

ESCALLADA, R ;

POSADAS, JMG ;

MACEIRA, B ;

PALLARDO, LM ;

PLUMED, JS ;

AMENABAR, JJ ;

LAMPREAVE, I ;

COLON, JAG ;

RAMOS, JP .

TRANSPLANTATION PROCEEDINGS, 1994, 26 (05) :2522-2524

[26] HEMOLYTIC-UREMIC SYNDROME IN A RENAL-TRANSPLANT RECIPIENT DURING OKT3 THERAPY [J].

DUSSOL, B ;

BRUNET, P ;

VACHERCOPONAT, H ;

SAINGRA, Y ;

CASANOVA, P ;

BERLAND, Y .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 1994, 9 (08) :1191-1193

[27] CONCOMITANT LOW-DOSE CYCLOSPORINE AND OKT3 THERAPY FOR RENAL-TRANSPLANT REJECTION [J].

HRICIK, DE ;

ZARCONI, J ;

SCHULAK, JA .

TRANSPLANTATION PROCEEDINGS, 1989, 21 (01) :1755-1757

[28] IMPROVING RENAL-TRANSPLANT OUTCOMES IN AFRICAN-AMERICANS WITH OKT3 INDUCTION THERAPY [J].

LIGHT, JA ;

KELLY, JL ;

AQUINO, A ;

NEU, L ;

DENAVAS, L ;

WILLIAMS, K .

TRANSPLANTATION PROCEEDINGS, 1993, 25 (04) :2436-2438

[29] PROLONGED NEUROLOGICAL DISABILITY FOLLOWING OKT3 THERAPY FOR ACUTE RENAL-TRANSPLANT REJECTION [J].

JEFFREY, RF ;

JOHNSON, MH ;

BAMFORD, JM ;

GILES, GR ;

BROWNJOHN, AM ;

WILL, EJ .

TRANSPLANTATION, 1993, 55 (03) :677-679

[30] TOXICITY OF OKT3 INCREASES WITH DOSAGE - A CONTROLLED-STUDY IN RENAL-TRANSPLANT RECIPIENTS [J].

PARLEVLIET, KJ ;

BEMELMAN, FJ ;

YONG, SL ;

HACK, CE ;

SURACHNO, J ;

WILMINK, JM ;

TENBERGE, IJM ;

SCHELLEKENS, PTA .

TRANSPLANT INTERNATIONAL, 1995, 8 (02) :141-146

← 1 2 3 4 5 →